Results 111 to 120 of about 44,670 (231)

Symptom Clusters and Symptom Burden in Cancer Survivors

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Context Limited information is available on the symptom burden and symptom clusters in cancer survivors. Objectives Describe the occurrence, severity, and distress of 44 symptoms; determine risk factors associated with a higher symptom burden; and evaluate for symptom clusters using symptom occurrence rates.
Marilyn J. Hammer, Carolyn Harris, Rachel Pozzar, Karin Snowberg, Steven M. Paul, Bruce A. Cooper, Maura E. Abbott, Susan Chang, Stacey Kenfield, Erin Van Blarigan, Katherine Van Loon, Jon D. Levine, Christine Miaskowski   +12 more
wiley   +1 more source

Male Breast Cancer: Growing Insights and Continuing Challenges

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Background Breast cancer (BC) in men accounts for less than 1% of all BC diagnoses worldwide. Despite its low incidence, the number of men being diagnosed is increasing. Historically perceived as a predominantly female disease, BC in men has received comparatively limited attention.
Sahar Iftikhar, Elissa Burr, Amal Freigoun, Theo Nearney, Christelle Q. Kanda, Hazel Robinson, Caroline Vermeren, Udana Wickramaratne, Matthew Everest, Luca Foley, Valerie Speirs   +10 more
wiley   +1 more source

Ontogeny of RSPO1, FOXL2, and RUNX1 during ovarian differentiation in the marsupial tammar wallaby

Developmental Dynamics, Volume 255, Issue 3, Page 340-361, March 2026.
Abstract Background RSPO1 and FOXL2 are female sex‐determining genes involved in the differentiation and organization of the ovary in some eutherian mammals. Mutations or loss of function of these genes are associated with partial to full sex reversal in mice, humans, and goats.
Monika R. Paranjpe, Yu Chen, Geoff Shaw, Marilyn B. Renfree   +3 more
wiley   +1 more source

Evaluation of Ginsenosides and Their Derivatives From <i>Panax ginseng</i> as Aromatase Inhibitors for Breast Cancer Treatment-An <i>in silico</i> study. [PDF]

Biomed Res Int
Madhan JG, Sekaran S, Akshaya RN, Venkatesan K, Kirupanandasamy K, Vijayakumar K, Jenifer N, Paul BC.   +7 more
europepmc   +1 more source

Evaluating Potential Effects of Chamomile (Matricaria chamomilla L.) in Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis

Food Science &Nutrition, Volume 14, Issue 3, March 2026.
Chamomile contains different bioactive agents such as flavonoids and phytosterols with potential anti‐inflammatory, antioxidant, analgesic, antispasmodic, and antitumor characteristics. According to our findings, animal studies have demonstrated the potential benefits of Chamomile consumption in the treatment of PCOS. In contrast, human studies yielded
Zahra Firoozi, Roghayeh Molani‐Gol, Vahideh Ebrahimzadeh‐Attari, Aida Malek‐Mahdavi   +3 more
wiley   +1 more source

Estrone-α-2-Deoxy-Glucoside as a Targeted Therapy for Triple-Negative Breast Cancer: Aromatase Inhibition and Cytotoxicity. [PDF]

Chem Biol Drug Des
Huang TY, Wang MR, Chou FP, Huang SC, Hsiao PY, Wu TK.   +5 more
europepmc   +1 more source

Aromatase [PDF]

, 2020
openaire   +1 more source

Leonurine: A Multifaceted Bioactive Alkaloid—From Pharmacological Mechanisms to Clinical Translation: A Narrative Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Leonurine (LEO), a bioactive alkaloid derived from the Leonurus genus, exhibits diverse pharmacological activities including uterotonic, antioxidant, anti‐inflammatory, antiapoptotic, Antitumor, and vasoprotective effects. This review aims to provide a comprehensive overview of LEO's pharmacokinetics, pharmacological mechanisms ...
Zhouyue Gu
wiley   +1 more source

The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review. [PDF]

Turk J Obstet Gynecol
Aydın G, Hatırnaz Ş, Saynur Hatırnaz E, Çetinkaya MB, Akdeniz M, Dokuzeylül Güngör N, Güler O, Merdanoğlu MA, Uzun A, Eroğlu S, Tosun Ö, Bahadırlı A, Yurtçu E, Keyif B, Güvey H, Gürkan N, Karlı P, Yılmaz Z, Baldini GM, Tavuz Aİ, Sparic R, Tabakova N, Tinelli A, Cao M, Ta SL, Hatırnaz O, Dahan M.   +26 more
europepmc   +1 more source

Evaluating distant recurrence‐free survival and location of metastasis in HER2+ breast cancer by ER status

International Journal of Cancer, Volume 158, Issue 5, Page 1184-1192, 1 March 2026.
What's New? The prognostic significance of the presence or absence of human epidermal growth factor receptor 2 (HER2) and estrogen receptor (ER) in breast cancer is well‐established. However, the relationship of HER2 and ER with distant disease recurrence and metastasis location is less well understood.
Damien Kaukonen, Alexander Ploner, Erwei Zeng, Jenny Bergqvist, Kamila Czene   +4 more
wiley   +1 more source